Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 26,426–26,450 of 27,380 studies, newest first · page 1058 of 1096.

January 1996 23

  1. 1996-01-01

    Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia

    ✓ Peer-reviewed Drug development Acta neuropathologica

    Key finding: Clinical and neuropsychological studies of chronically institutionalized patients with schizophrenia indicate that severe cognitive impairment and functional disability in late life are very prevalent. +3 more findings

  2. 1996-01-01

    Apolipoprotein E alleles as risk factors in Alzheimer's disease

    ✓ Peer-reviewed Genetics Annual review of medicine

    Key finding: A major susceptibility locus, apolipoprotein E (APOE, gene; apoE, protein) is associated with risk and age of onset distributions for the common familial and sporadic late-onset AD.

  3. 1996-01-01

    Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984)

    ✓ Peer-reviewed Vascular contributions Neurology

    Key finding: After the first year, a 50% increase was observed in Alzheimer's disease in the cohort compared with that in the community. +1 more finding

  4. 1996-01-01

    Relationship between falls and stride length variability in senile dementia of the Alzheimer type

    ✓ Peer-reviewed Clinical safety Gerontology

    Key finding: The findings indicated that the number of fallers was significantly higher in moderate-stage SDAT patients than in the mild-stage patients. +3 more findings

  5. 1996-01-01

    Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes

    ✓ Peer-reviewed Inflammation and the immune system Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Induction depended on productive viral infection: not only did the kinetics of MIP-1 peptide induction closely follow those of viral replication, but monocyte cultures inoculated with heat-inactivated virus or infected in the presence of AZT failed to produce these chemokine beta peptides. +3 more findings

  6. 1996-01-01

    Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP

    ✓ Peer-reviewed Brain tissue and pathology Proceedings of the National Academy of Sciences of the United States of America

    Key finding: In this disorder, the vascular amyloid in tissue sections and the approximately 7.5-kDa fragment extracted from amyloid are labeled by antibodies to epitopes located in the PrP sequence including amino acids 90-147. +3 more findings

  7. 1996-01-01

    Medical comorbidity in schizophrenia

    ✓ Peer-reviewed Brain tissue and pathology Schizophrenia bulletin

    Key finding: Patients with comorbid conditions are usually excluded from research studies, although they probably represent the majority of individuals with schizophrenia. +3 more findings

  8. 1996-01-01

    Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

    ✓ Peer-reviewed Cognitive tests and assessment Journal of geriatric psychiatry and neurology

    Key finding: Twenty-eight subjects completed a baseline evaluation and at least one assessment during treatment. +3 more findings

  9. 1996-01-01
  10. 1996-01-01

    Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man

    ✓ Peer-reviewed Lewy body dementia Journal of neural transmission (Vienna, Austria : 1996)

    Key finding: The partial elucidation of the processes underlie the selective action of neurotoxic substances such as 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), has however revealed possible molecular mechanisms that give rise to neuronal death. +1 more finding

  11. 1996-01-01

    Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: Clinical assessment

    ✓ Peer-reviewed Down syndrome and Alzheimer's Clinical genetics

    Key finding: We report on the clinical and cytogenetic assessment of five cases of Down syndrome phenotype with either a partial duplication of chromosome 21 or a normal karyotype, and we quote a case of del (21q) syndrome. +4 more findings

  12. 1996-01-01

    Endogenous opioids in frontal cortex of patients with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience letters

    Key finding: The results of this study show that there is an increase in the levels of leu-enkephalin and dynorphin A in the frontal cortex of patients with DS as compared to the control group. +1 more finding

  13. 1996-01-01

    Modulation of blood-brain barrier permeability

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of drug targeting

    Key finding: Genetic and other defects leading to brain changes in Down syndrome, Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, Gaucher disease, hypertension and other disorders are rapidly being identified. +2 more findings

  14. 1996-01-01

    Prevalence of dementia in adults with and without Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's American journal of mental retardation : AJMR

    Key finding: No significant differences were found between adults under 50 years of age with and without Down syndrome. +1 more finding

  15. 1996-01-01

    Word-finding deficits persist after left anterotemporal lobectomy

    ✓ Peer-reviewed Digital health tools Archives of neurology

    Key finding: Differences between these results and those of previous studies may reflect differences in extent of surgical resection and/or differential sensitivity of psychometric measures of naming to word-finding problems. +1 more finding

  16. 1996-01-01

    Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts

    ✓ Peer-reviewed How common it is European neurology

    Key finding: Cerebral atrophy (CA) in stroke patients is associated with poststroke dementia and may reflect underlying neurodegenerative pathology. +2 more findings

  17. 1996-01-01

    Clinical features of frontal lobe dementia in comparison to Alzheimer's disease

    ✓ Peer-reviewed Disparities Journal of neural transmission. Supplementum

    Key finding: In addition, we shall describe the results of retrospective and prospective neuropsychiatric studies of a group of DFT patients.

  18. 1996-01-01

    Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study

    ✓ Peer-reviewed Disparities International psychogeriatrics

    Key finding: An age-stratified random sample of men and women, aged 55 years and older, was drawn from a community-based population in the rural area of Ballabgarh in northern India. +4 more findings

  19. 1996-01-01

    Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease

    ✓ Peer-reviewed Caregiving Alzheimer disease and associated disorders

    Key finding: The DSRS provides a simple, valid, and sensitive measure of impairment associated with AD.

  20. 1996-01-01

    The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery

    ✓ Peer-reviewed Getting a diagnosis European neurology

    Key finding: This study aimed at investigating the clinical usefulness of the Mental Deterioration Battery (MDB) in the neuropsychological diagnosis and characterization of the dementia syndrome.

  21. 1996-01-01

    Is a randomized trial of antioxidants in the primary prevention of Alzheimer disease warranted?

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: Laboratory studies suggest that oxidative mechanisms may be involved in the pathogenesis of Alzheimer disease and raise the possibility that antioxidant nutrients could be used in disease prevention. +2 more findings

  22. 1996-01-01

    Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: The primary outcome of the study is the time to reach any one of the following four endpoints: death, institutionalization, loss of two of three basic activities of daily living, and progression of Clinical Dementia Rating (CDR) stage from 2 to 3. +4 more findings

  23. 1996-01-01

    Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions

    ✓ Peer-reviewed Biomarkers Neurobiology of disease

    Key finding: A congenic pair was used: the C5-sufficient (C5+) B10.D2/nSnJ strain with the functional allele (Hc1) from the C57BL/10J donor strain was compared with the C5-deficient (C5-) B10.D2/oSnJ with the Hc0 allele from the C5-deficient DBA/2J donor strain. +2 more findings

December 1995 2

  1. 1995-12 month only

    Apolipoprotein E, synaptic plasticity and Alzheimer's disease

    ✓ Peer-reviewed Genetics Annals of medicine

    Key finding: Entorhinal cortex-lesioned rats have been used extensively to examine the molecular mechanisms associated with deafferentation and reinnervation in the CNS; studies of the role of apoE in this process using this animal model are described. +2 more findings

  2. 1995-12-01

    Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro

    ✓ Peer-reviewed Down syndrome and Alzheimer's Nature

    Key finding: Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation, and adults with DS develop Alzheimer's disease. +1 more finding

Browse the library by subject, with the full score breakdown →